ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.62
+0.09 (1.38%)
Aug 14, 2025, 11:26 AM - Market open
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $59.83 million as of August 14, 2025. Its market cap has increased by 89.10% in one year.
Market Cap
59.83M
Enterprise Value
69.07M
1-Year Change
89.10%
Ranking
Category
Stock Price
$6.62
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $59.83M, an increase of 2,903.39%. That is a compound annual growth rate of 10.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 60.10M | 30.95% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | 42.92M | 15.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |